[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100195543":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":10,"locations":21,"responsibleParty":49,"collaborators":10,"id":51,"slug":52,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":57,"eligibilityCriteria":58,"healthyVolunteers":59,"sex":60,"minAge":61,"maxAge":10,"enrollmentInfo":62,"targetDuration":10,"studyType":65,"phases":10,"briefSummary":66,"conditions":67,"keywords":73,"overallStatus":23,"whyStopped":10,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"University Hospital of Cologne","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Antiinfectives",null,"To analyze the efficacy of antiinfectives at high risk patients",[13],"Drug: Antiinfectives",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":19},"DRUG","To analyze to efficacy of (novel) drug therapies",[9],[20],"Antifungals, Antibacterials, Antivirals",[22],{"facility":5,"status":23,"city":24,"state":25,"zip":26,"country":27,"countryCode":28,"cosmosGeoPoint":29,"geoPoint":34,"contacts":35},"RECRUITING","Cologne","North Rhine-Westphalia","50924","Germany","DE",{"type":30,"coordinates":31},"Point",[32,33],6.95,50.93333,{"lat":33,"lon":32},[36,42,46],{"name":37,"role":38,"phone":39,"phoneExt":40,"email":41},"Jörg Janne Vehreschild, Dr. med.","CONTACT","+0049 (0)221 478-6494","-6494","janne.vehreschild@ctuc.de",{"name":43,"role":38,"phone":44,"phoneExt":40,"email":45},"Oliver Andreas Cornely, Prof. Dr. med.","0049 (0)221 478-6494","oliver.cornely@ctuc.de",{"name":47,"role":48,"phone":10,"phoneExt":10,"email":10},"Jörg J. Vehreschild, Dr. med.","PRINCIPAL_INVESTIGATOR",{"type":50,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100195543","cologne-cohort-of-neutropenic-patients-coconut-100195543",false,"NCT01821456","Cologne Cohort of Neutropenic Patients (CoCoNut)","The Cologne Cohort of Neutropenic Patients (CoCoNut) - a Non-interventional Cohort Study Assessing Risk Factors, Interventions, and Outcome of Immunosuppressed Patients With or Without Opportunistic Infections","CoCoNut","Inclusion Criteria:\n\n* immunosuppressed patients\n\nExclusion Criteria:\n\n* none",true,"ALL","1 Year",{"count":63,"type":64},100000,"ESTIMATED","OBSERVATIONAL","The Cologne Cohort of Neutropenic Patients (CoCoNut) is a non-interventional cohort study assessing risk factors, interventions, and outcome of immunosuppressed patients with or without opportunistic infections.",[68,69,70,71,72],"Hematological Malignancies","Cancer","Chemotherapy","Neutropenia","Immunosuppression",[74,75,76,77,78,79],"hematological malignancies","cancer","chemotherapy","anti-infectives","treatment","outcome","2013-03-26",{"date":82,"type":64},"2013-04-01",{"date":84,"type":10},"1995-01",{"date":86,"type":64},"2050-12",{"name":5,"class":6},1]